Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.701
-0.028 (-3.82%)
At close: Mar 9, 2026, 4:00 PM EDT
0.696
-0.005 (-0.76%)
After-hours: Mar 9, 2026, 4:00 PM EDT
Trinity Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 13 | 15 | 16 | 38 | 30 | 80 | |
| Market Cap Growth | -2.00% | -6.42% | -56.55% | 26.22% | -62.47% | 268.69% | |
| Enterprise Value | 129 | 106 | 69 | 100 | 100 | 160 | |
| Last Close Price | 0.73 | 0.88 | 2.15 | 4.95 | 7.15 | 19.05 | |
| PE Ratio | - | - | - | - | 34.16 | - | |
| Forward PE | - | - | - | - | 28.60 | 10.03 | |
| PS Ratio | 0.27 | 0.25 | 0.29 | 0.60 | 0.37 | 0.78 | |
| PB Ratio | - | -0.44 | -0.68 | -17.34 | -93.70 | -35.89 | |
| P/FCF Ratio | - | - | - | - | 2.62 | 3.88 | |
| P/OCF Ratio | - | - | - | - | 2.26 | 3.35 | |
| PEG Ratio | - | - | - | - | 1.91 | 0.31 | |
| EV/Sales Ratio | 2.65 | 1.73 | 1.22 | 1.60 | 1.23 | 1.57 | |
| EV/EBITDA Ratio | - | - | - | - | 10.91 | 7.41 | |
| EV/EBIT Ratio | - | - | - | - | 15.51 | 8.65 | |
| EV/FCF Ratio | - | - | - | - | 8.76 | 7.77 | |
| Debt / Equity Ratio | -2.14 | -2.86 | -2.81 | -33.18 | -310.84 | -47.02 | |
| Debt / EBITDA Ratio | - | - | - | - | 10.80 | 4.85 | |
| Debt / FCF Ratio | - | - | - | - | 8.68 | 5.08 | |
| Net Debt / Equity Ratio | -2.12 | -2.72 | -2.66 | -30.16 | -229.61 | -34.71 | |
| Net Debt / EBITDA Ratio | -8.26 | -7.34 | -4.50 | -5.85 | 7.98 | 3.58 | |
| Net Debt / FCF Ratio | -85.25 | -20.80 | -5.16 | -32.45 | 6.41 | 3.75 | |
| Asset Turnover | 0.48 | 0.76 | 0.75 | 0.59 | 0.65 | 0.78 | |
| Inventory Turnover | 1.50 | 2.04 | 1.76 | 1.75 | 1.61 | 1.72 | |
| Quick Ratio | 0.47 | 0.62 | 1.11 | 1.28 | 0.41 | 1.92 | |
| Current Ratio | 1.03 | 1.28 | 2.60 | 2.69 | 0.72 | 3.08 | |
| Return on Equity (ROE) | - | - | - | - | - | -482.20% | |
| Return on Assets (ROA) | -9.46% | -10.53% | -13.15% | -8.00% | 3.24% | 8.82% | |
| Return on Invested Capital (ROIC) | -24.82% | -27.35% | -30.88% | -19.81% | 8.74% | 22.32% | |
| Return on Capital Employed (ROCE) | -22.00% | -19.20% | -35.90% | -18.10% | 35.10% | 17.80% | |
| Earnings Yield | -282.10% | -207.25% | -146.53% | -108.70% | 2.93% | -8.02% | |
| FCF Yield | -10.40% | -29.96% | -75.41% | -5.36% | 38.23% | 25.80% | |
| Buyback Yield / Dilution | -171.15% | -134.62% | -13.46% | -61.40% | - | - | |
| Total Shareholder Return | -171.15% | -134.62% | -13.46% | -61.40% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.